AS

Angela Sormani

CBPE Sells Rosemont to Perrigo

London, Uk-based CBPE Capital has sold Rosemont Pharmaceuticals to Perrigo Company, the $10 billion US listed pharmaceuticals business. CBPE acquired Rosemont in August 2006. The sale to Perrigo represents an investment multiple of 3.25x.

2 min read · 12 February 2013

Silver Airways Names Dave Pflieger President and CEO

Silver Airways’ board of directors has appointed David H. Pflieger, Jr to the position of President and CEO, effective May 1, 2013. Pflieger, who also will join the company’s board of directors, will succeed Darrell Richardson who recently retired.

6 min read · 12 February 2013

Leach Joins Ballard Spahr

Travis J. Leach has joined Ballard Spahr as a partner in the Phoenix office. Leach handles mergers and acquisitions, public offerings, private placements, corporate governance matters, and Sarbanes-Oxley and SEC compliance.

2 min read · 12 February 2013

JPTF Completes Growth Capital Transaction

Texas-based Johnson Plate & Tower Fabrication, a steel fabricator focused on the wind power industry, has completed a growth capital financing. The Peakstone Group served as JPTF's exclusive financial advisor in connection with this transaction. Terms of the transaction were not disclosed.

1 min read · 12 February 2013

Inaki Echave to Join Blackstone to Focus on Spain and Portugal

Inaki Echave will join Blackstone as a managing director, with primary responsibility for Spain and Portugal. Echave was most recently a partner with Magnum Capital, an independent buy-out fund on the Iberian Peninsula. He will work alongside Claudio Boada, Blackstone’s chairman for Iberia.

3 min read · 12 February 2013

peHUB First Read

This morning First Read brings you the latest on private equity manager bonuses, Spark Capital's oversubscribed fund close and whether Facebook could possibly acquire LinkedIn?

1 min read · 12 February 2013

Avita Medical Appoints Former Bay City capital Venture Partner to Board

Regenerative medicine company Avita Medical has appointed Dr. Michael S. Perry, vice president and senior global program head, stem cell therapy at Novartis Pharmaceuticals to the company's board of directors. From 2005 to 2012, Perry was a venture partner with Bay City Capital, a California-based venture capital firm managing over US$1.6 billion invested predominantly in life science companies.

3 min read · 11 February 2013

Cooley Appoints Latham & Watkins Partner

Cooley has appointed Jamie Leigh as a partner and member of the mergers & acquisitions group. Leigh, who will be based in Cooley's San Francisco office, joins the firm from Latham & Watkins. Leigh's practice focuses on sophisticated, complex mergers and acquisitions, joint ventures, private equity investments and restructurings.

2 min read · 11 February 2013

Silicon Legal Strategy Appoints Kirkland & Ellis Associate

Silicon Legal Strategy has appointed Brendan Herron as the newest associate in its San Francisco office. Prior to joining SLS, Brendan was at Kirkland & Ellis in Chicago, where he represented private equity and venture capital funds and their portfolio companies in M&A transactions, equity and debt financings, public offerings and key strategic business relationships.

2 min read · 11 February 2013

Tony Mou Joins Sheppard Mullin Shanghai

Tony Mou has joined Sheppard, Mullin, Richter & Hampton as a partner in the corporate practice group and will be based in the firm's Shanghai office. Mou joins from Morgan Lewis in Beijing. Mou will represent private equity/venture capital clients, entrepreneurs, venture-backed companies as well as inbound and outbound mergers and acquisitions.

2 min read · 11 February 2013

Showing 2,591 to 2,600 of 5,350 results
1…259261…535